Treatments

These posts deal with some the possible treatments for prostate cancer.

Home » Treatments

VIDEO: Dr. Uri Lindner “MR-guided Laser Focal Therapy for Prostate Cancer.”

  Dr. Uri Lindner MD, FRCSC Uro-Oncology Fellow Princess Margaret Cancer Centre Toronto, ON, Canada Dr. Lindner is an associate of Dr. John Trachtenberg who has developed a ground-breaking approach to the treatment of prostate cancer. In general approach, this procedure has some similarities to a lumpectomy in the treatment of breast cancer. Despite its recent emergence as an option for treating prostate cancer, MR-guided laser focal therapy for prostate cancer is already earning international attention and attracting increasing interest. CLICK ON THE ARROW TO START THE VIDEO Complete Presentation “MR-guided Laser Focal Therapy for Prostate Cancer.” High Definition 35 […]

VIDEO: Dr. Uri Lindner “MR-guided Laser Focal Therapy for Prostate Cancer.” Read More »

New Ways to Target Androgens in Prostate Cancer

Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects. Read more.

New Ways to Target Androgens in Prostate Cancer Read More »

Survival Better with Continuous ADT

CHICAGO—Intermittent androgen deprivation therapy (ADT) has some quality-of-life (QOL) benefits for men with metastatic prostate cancer (PCa), but overall survival times are inferior to those seen with continuous ADT, according to the findings of a 17-year study (SWOG9346) presented at the American Society for Clinical Oncology 2012 annual meeting. Read More

Survival Better with Continuous ADT Read More »

Focal HIFU

It is hoped the new treatment, which involves heating only the tumours with a highly focused ultrasound, will mean men can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies. Read more.

Focal HIFU Read More »

Management of Metastatic Castration-resistant Prostate Cancer

Management of Metastatic Castration-resistant Prostate Cancer Abstract The management of men with metastatic castration-resistant prostate cancer (CRPC) has taken several leaps forwards in the last two years, with the demonstration of improved overall survival with three novel agents (sipuleucel-T, cabazitaxel and abiraterone acetate) and a significant delay in skeletal-related events observed with denosumab. … Click here for more.

Management of Metastatic Castration-resistant Prostate Cancer Read More »

Scroll to Top